RPL5P29

Across TCGA pan-cancer cohorts, RPL5P29 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of RPL5P29’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPL5P29 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL5P29 is over-expressed in tumor, although a few such as BRCA and UCEC show the opposite, repressed pattern.

KIRC, BRCA, and LUAD are the cancer types where RPL5P29 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL5P29 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.192	<.001	12	view →
BRCA	Female	II,III,IV	−0.276	<.001	6	view →
LUAD	All	All	+0.252	<.001	5	view →
KIRP	All	IV	+0.334	.031	3	view →
LIHC	All	All	+0.083	.002	3	view →
UCEC	All	All	−0.309	.022	2	view →
PAAD	Male	All	−0.204	.014	2	view →
LUSC	Male	III,IV	+0.345	.016	1	view →
KICH	All	All	−0.126	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

RPL5P29–KIRC

Open the KIRC breakdown →